AMRA, a medical technology company based out of Linköping, Sweden, has received FDA clearance for AMRA Profiler, an MR solution that measures a patient’s fat volumes, fat fractions and lean tissue volumes.

The solution captures these measurements with a single six-minute whole-body MRI scan, providing physicians with details that can help them make their diagnosis.  

“We are delighted with the FDA’s decision,” Eric Converse, CEO of AMRA, said in a prepared statement. “The challenges facing healthcare systems across the world are well-documented. Cost constraints, together with societal issues such as obesity and an aging population, are putting hospitals and private clinics under increasing pressure. AMRA® Profiler helps address these challenges by providing physicians with the most detailed body composition assessment and imaging available, cost-effectively and with minimal intrusion to the patient.”

AMRA Profiler is already available in Sweden, the U.K. and Germany.